JPL Wealth Management LLC Acquires Shares of 47,212 Sanofi (NASDAQ:SNY)

JPL Wealth Management LLC acquired a new stake in shares of Sanofi (NASDAQ:SNY) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 47,212 shares of the company’s stock, valued at approximately $2,277,000.

Other institutional investors have also modified their holdings of the company. Abel Hall LLC boosted its holdings in shares of Sanofi by 1.8% during the 4th quarter. Abel Hall LLC now owns 10,990 shares of the company’s stock worth $530,000 after purchasing an additional 194 shares during the last quarter. Angeles Investment Advisors LLC grew its stake in shares of Sanofi by 1.9% in the third quarter. Angeles Investment Advisors LLC now owns 11,323 shares of the company’s stock worth $653,000 after acquiring an additional 210 shares in the last quarter. Keudell Morrison Wealth Management grew its stake in shares of Sanofi by 1.7% in the fourth quarter. Keudell Morrison Wealth Management now owns 12,928 shares of the company’s stock worth $624,000 after acquiring an additional 217 shares in the last quarter. Bailard Inc. grew its stake in shares of Sanofi by 1.4% in the fourth quarter. Bailard Inc. now owns 16,359 shares of the company’s stock worth $789,000 after acquiring an additional 220 shares in the last quarter. Finally, Old Port Advisors grew its stake in shares of Sanofi by 0.6% during the fourth quarter. Old Port Advisors now owns 36,704 shares of the company’s stock worth $1,770,000 after purchasing an additional 232 shares in the last quarter. Hedge funds and other institutional investors own 14.04% of the company’s stock.

Sanofi Stock Performance

Sanofi stock opened at $57.69 on Thursday. Sanofi has a 12-month low of $45.22 and a 12-month high of $60.12. The company has a market capitalization of $146.41 billion, a price-to-earnings ratio of 23.17, a price-to-earnings-growth ratio of 1.01 and a beta of 0.58. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.46 and a quick ratio of 1.14. The firm’s fifty day moving average price is $53.27 and its 200 day moving average price is $52.81.

Sanofi (NASDAQ:SNY) last posted its quarterly earnings results on Thursday, January 30th. The company reported $0.70 EPS for the quarter, meeting the consensus estimate of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. On average, research analysts forecast that Sanofi will post 4.36 EPS for the current fiscal year.

Wall Street Analyst Weigh In

SNY has been the subject of several research analyst reports. Sanford C. Bernstein upgraded shares of Sanofi to a “strong-buy” rating in a research note on Thursday, January 30th. Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a “sell” rating to a “hold” rating in a report on Thursday, January 30th. Finally, StockNews.com cut shares of Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Two research analysts have rated the stock with a hold rating, one has given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Buy” and an average target price of $60.00.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.